management of esophageal/gej cancers: an interdisciplinary tumor board on adjuvant immunotherapy
Published 3 years ago • 3.5K plays • Length 59:58Download video MP4
Download video MP3
Similar videos
-
1:04:49
navigating multidisciplinary care with immunotherapy in esophageal/gej cancer
-
59:06
gastric and gej cancers: treatment planning and sequencing in the era of immunotherapy
-
10:45
new data on adjuvant treatment of esophageal cancer
-
1:30:00
checkpoint inhibition in gi cancers: recent advances and their application in clinical practice
-
47:55
advanced gastroesophageal cancers: maximizing the benefits of novel immunotherapy approaches
-
30:31
gastroesophageal cancer: current positioning of immunotherapy
-
21:34
new evolutions for the neo-adjuvant and adjuvant treatment of esophageal cancer
-
2:25
adjuvant therapy for esophageal cancer
-
56:48
immunotherapy for gastroesophageal cancer
-
4:14
adjuvant nivolumab in patients with resected esophageal or gej cancer (checkmate 577)
-
19:44
emerging biomarkers and novel therapies for esophageal cancer
-
9:53
chemotherapy, immunotherapy, targeted therapy for gastric cancer, esophageal cancer -edusurg clinics
-
17:43
the surgical management of esophageal cancer
-
3:45
immunotherapy for cancers of the oesophagus and stomach - online interview
-
17:37
what is the most optimum perioperative treatment in esophageal cancer
-
12:10
role of chemotherapy in esophagus and gastroesophageal junction cancers - evidence based overview
-
51:42
surgical management of esophageal cancer
-
1:25
pd-1 and pd-l1 expression in esophageal and gastric cancer
-
30:59
algorithms for management of locally-advanced and metastatic gastric & ge junction adenocarcinomas